INTERNATIONAL PATENT: INCYTE CORPORATION FILES APPLICATION FOR "COMBINATION THERAPY USING A KRAS G12D INHIBITOR AND PD-1 INHIBITOR OR PD-L1 INHIBITOR"

GENEVA, April 21 -- INCYTE CORPORATION (1801 AUGUSTINE CUT-OFFWILMINGTON, Delaware 19803) filed a patent application (PCT/US2024/050391) for "COMBINATION THERAPY USING A KRAS G12D INHIBITOR AND PD-1 INHIBITOR OR PD-L1 INHIBITOR" on Oct 08, 2024. With publication no. WO/2025/080593, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FARREN, Matthew (1801 AUGUSTINE CUT-OFFWILMINGTON, Delaware 19803), KIM, Sunkyu (1801 AUGUSTINE CUT-OFFWILMINGTON, Delaware 19803), ROMAN, Valerie (1801 AUGUSTINE CUT-OFFWilmington, Delaware 19803...